Sign up to save your podcasts
Or
Share E.O. - Lowering Drug Prices By Once Again Putting Americans First
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E.O. - Lowering Drug Prices By Once Again Putting Americans First
Trump's 2025 Plan to Cut Drug Costs
President Trump’s April 15, 2025, Executive Order "Lowering Drug Prices by Once Again Putting Americans First" sets a sweeping agenda to reduce prescription drug costs. The order promotes domestic pharmaceutical production via tariffs, aligns Medicare drug pricing reforms to treat small molecules like biologics, caps insulin copayments, expands drug importation, and demands greater transparency from Pharmacy Benefit Managers. The policy also focuses on lowering costs for seniors, stimulating innovation, and combating anti-competitive behaviors in the pharmaceutical industry. Critics warn of price increases, safety concerns, and threats to innovation, underscoring the complexities of reforming U.S. drug policy.
President Trump’s April 15, 2025, Executive Order "Lowering Drug Prices by Once Again Putting Americans First" sets a sweeping agenda to reduce prescription drug costs. The order promotes domestic pharmaceutical production via tariffs, aligns Medicare drug pricing reforms to treat small molecules like biologics, caps insulin copayments, expands drug importation, and demands greater transparency from Pharmacy Benefit Managers. The policy also focuses on lowering costs for seniors, stimulating innovation, and combating anti-competitive behaviors in the pharmaceutical industry. Critics warn of price increases, safety concerns, and threats to innovation, underscoring the complexities of reforming U.S. drug policy.
View all episodes
By C. LegeTrump's 2025 Plan to Cut Drug Costs
President Trump’s April 15, 2025, Executive Order "Lowering Drug Prices by Once Again Putting Americans First" sets a sweeping agenda to reduce prescription drug costs. The order promotes domestic pharmaceutical production via tariffs, aligns Medicare drug pricing reforms to treat small molecules like biologics, caps insulin copayments, expands drug importation, and demands greater transparency from Pharmacy Benefit Managers. The policy also focuses on lowering costs for seniors, stimulating innovation, and combating anti-competitive behaviors in the pharmaceutical industry. Critics warn of price increases, safety concerns, and threats to innovation, underscoring the complexities of reforming U.S. drug policy.
President Trump’s April 15, 2025, Executive Order "Lowering Drug Prices by Once Again Putting Americans First" sets a sweeping agenda to reduce prescription drug costs. The order promotes domestic pharmaceutical production via tariffs, aligns Medicare drug pricing reforms to treat small molecules like biologics, caps insulin copayments, expands drug importation, and demands greater transparency from Pharmacy Benefit Managers. The policy also focuses on lowering costs for seniors, stimulating innovation, and combating anti-competitive behaviors in the pharmaceutical industry. Critics warn of price increases, safety concerns, and threats to innovation, underscoring the complexities of reforming U.S. drug policy.